TetraLogic Pharmaceuticals agrees to acquire shape pharmaceuticals inc


Monday, 7 Apr 2014 04:05pm EDT 

TetraLogic Pharmaceuticals Corp:Executes definitive agreement to acquire by merger 100 pct of Shape Pharmaceuticals, a privately-held biotechnology company developing suberohydroxamic acid phenyl ester (SHAPE), adding a second clinical-stage oncology compound to the TetraLogic portfolio.Says it will acquire Shape for an upfront cash payment of $13 mln. 

Company Quote

2.42
0.06 +2.54%
2 Jul 2015